• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE 1.14% 43.5¢

RECCE PHARMACEUTICALS LTD

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

RCE receives Indonesian approval for Phase 3 trial

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RCE 10/02/25 6 1.8K
10/02/25 Last post  Neet$ Comments Created with Sketch.  6  Views Created with Sketch.  1.8K 
RCE 04/02/25 10 3.2K
04/02/25 Last post  BC1954 Comments Created with Sketch.  10  Views Created with Sketch.  3.2K 
RCE 04/02/25 54 25K
Metals & Mining SECTOR NEWS

China Imposes Molybdenum Export Controls Sparking Demand for US Suplier

EVR
11 Feb 2025
EV RESOURCES LTD
04/02/25 Last post  zecs Comments Created with Sketch.  54  Views Created with Sketch.  25K 
RCE 28/01/25 9 4.0K
28/01/25 Last post  Lucretious Comments Created with Sketch.  9  Views Created with Sketch.  4.0K 
RCE
[INTERVIEW] Recce Pharmaceuticals Phase 3 Diabetic Foot Infection Trial fast-tracked, thanks to Indonesian approval
09/12/24 0 474
09/12/24 Last post  TheMarketOnline Comments Created with Sketch.  0  Views Created with Sketch.  474 
RCE 08/12/24 28 10K
08/12/24 Last post  bcr Comments Created with Sketch.  28  Views Created with Sketch.  10K 
RCE 03/12/24 10 3.7K
03/12/24 Last post  BC1954 Comments Created with Sketch.  10  Views Created with Sketch.  3.7K 
RCE 29/11/24 3 1.8K
29/11/24 Last post  Bpharma Comments Created with Sketch.  3  Views Created with Sketch.  1.8K 
RCE 26/11/24 5 2.0K
26/11/24 Last post  Rykster Comments Created with Sketch.  5  Views Created with Sketch.  2.0K 
RCE 21/11/24 1 657
21/11/24 Last post  ToiletPaper Comments Created with Sketch.  1  Views Created with Sketch.  657 
RCE 21/11/24 16 5.6K
21/11/24 Last post  ToiletPaper Comments Created with Sketch.  16  Views Created with Sketch.  5.6K 
RCE 15/11/24 1 866
15/11/24 Last post  Trader36 Comments Created with Sketch.  1  Views Created with Sketch.  866 
RCE 13/11/24 0 421
13/11/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  421 
RCE 12/11/24 20 7.9K
12/11/24 Last post  BelowAverage Comments Created with Sketch.  20  Views Created with Sketch.  7.9K 
RCE 12/11/24 7 3.8K
12/11/24 Last post  BelowAverage Comments Created with Sketch.  7  Views Created with Sketch.  3.8K 
RCE 06/11/24 0 472
06/11/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  472 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Correction to Appendix 4C and Quarterly Activities Report
06 Feb 11:29
 
Quarterly Activities/Appendix 4C Cash Flow Report
31 Jan 17:26
 
Patient Dosing Complete in Phase II ABSSSI Trial of R327G
21 Jan 09:57
 
Regulatory Approval for Registrational Phase 3 R327G Trial
09 Dec 09:05
 
Trading Halt
05 Dec 09:21
 
Presentation - Ord Minnett Biotech & MedTech Conference
28 Nov 12:42
 
View More arrow Created with Sketch.
(20min delay)
Last
43.5¢
Change
-0.005(1.14%)
Mkt cap ! $100.8M
Open High Low Value Volume
43.5¢ 44.0¢ 43.5¢ $53.69K 123.3K

Buyers (Bids)

No. Vol. Price($)
2 138196 43.5¢
 

Sellers (Offers)

Price($) Vol. No.
44.0¢ 47411 1
View Market Depth
Last trade - 15.48pm 11/02/2025 (20 minute delay) ?
Last
43.5¢
  Change
-0.005 ( 0.11 %)
Open High Low Volume
43.5¢ 44.0¢ 43.5¢ 27619
Last updated 14.51pm 11/02/2025 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.